Proto Labs (WBO:PRLB) ROCE % : 4.66% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Proto Labs ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Proto Labs's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.66%.

Proto Labs ROCE % Historical Data

The historical data trend for Proto Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Labs ROCE % Chart

Proto Labs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

13.54

8.68

5.31

3.48

3.85

Proto Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															0.69	2.10	3.19	5.92	4.66

Proto Labs ROCE % Calculation

Proto Labs's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	26.026	/	( ( (757.247 - 67.572)	+	(708.248 - 45.557) )	/ 2 )
	=	26.026	/	( (689.675	+	662.691)	/ 2 )
	=	26.026	/	676.183
	=	3.85 %

Proto Labs's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	30.9	/	( ( (734.838 - 69.926)	+	(708.248 - 45.557) )	/ 2 )
	=	30.9	/	( ( 664.912	+	662.691 )	/ 2 )
	=	30.9	/	663.8015
	=	4.66 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Proto Labs (WBO:PRLB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Proto Labs ROCE % Related Terms

Thank you for viewing the detailed overview of Proto Labs's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Labs (WBO:PRLB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Proto Labs Inc (WBO:PRLB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PRLB:USA PRZ:Germany

Address

5540 Pioneer Creek Drive, Maple Plain, MN, USA, 55359

Website

https://www.protolabs.com

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. The majority of its revenue is derived from the United States of America.